CYTEGRITY
DEAD

Serial Number

88583412

Owner

CSL BEHRING GENE THERAPY, INC.

Attorney

Scott D. Woldow

Filing Date

Aug 19, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CYTEGRITY Trademark

Serial Number: 88583412

CYTEGRITY is a trademark filed by CSL BEHRING GENE THERAPY, INC. on August 19, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CSL BEHRING GENE THERAPY, INC. (8 trademarks)

5151 E. BROADWAY BOULEVARD
TUSCON, AZ 85711

Entity Type: 03

Calimmune, Inc. (13 trademarks)

Suite 1020
Tucson, AZ 85711

Entity Type: 03

Trademark Details

Filing Date

August 19, 2019

Registration Date

Not Registered

Published for Opposition

January 5, 2021

Goods & Services

Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders

Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 8, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 8, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 9, 2023 EXRA
SOU EXTENSION 5 GRANTED
Aug 8, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 8, 2023 AITU
SOU EXTENSION 5 FILED
Aug 1, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 1, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2023 EXRA
SOU EXTENSION 4 GRANTED
Feb 2, 2023 EX4G
SOU EXTENSION 4 FILED
Feb 2, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 2, 2023 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 4, 2023 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 4, 2022 EXRA
SOU EXTENSION 3 GRANTED
Aug 2, 2022 EX3G
SOU EXTENSION 3 FILED
Aug 2, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 2, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2022 EXRA
SOU EXTENSION 2 GRANTED
Feb 2, 2022 EX2G
SOU EXTENSION 2 FILED
Feb 2, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 2, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jul 28, 2021 EX1G
SOU EXTENSION 1 FILED
Jul 28, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 28, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 2, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 2, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 23, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 23, 2020 GNFR
FINAL REFUSAL WRITTEN
Jun 23, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2020 CRFA
ASSIGNED TO LIE
Jun 3, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 26, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 26, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 26, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 26, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2019 NWOS
NEW APPLICATION ENTERED
Aug 22, 2019 NWAP